Abstract:Objective To explore the effects of calycosin (CA) on isoprenaline (ISO)-induced cardiac hypertrophy. Methods Thirty C57 mice were randomly divided into the control group(n=10),ISO group(n=10),and CA+ISO group(n=10). The mice in ISO group received intraperitoneal injection with ISO(50 mg·kg-1·d-1),those in CA+ISO group received intraperitoneal injection with ISO(50 mg·kg-1·d-1) and intragastric gavage with CA (50 mg · kg-1 · d-1),and those in control group received intraperitoneal injection with normal saline(50 ml · kg-1 · d-1). At 14 days after the treatment,the mice were measured for body mass(BM),sacrificed and harvested for cardiac specimens. The heart mass(HM),tibial length(TL) and myocardial cell cross-sectional area were measured. Real-time quantitative PCR was used to determine the mRNA expression of atrial natriuretic peptide(ANP) and β-myosin heavy chain(β-MHC). Immunoblotting was used to investigate the molecular pathway related to cardiac hypertrophy. Primary cultured rat cardiac myocytes were divided into the control group,ISO group and ISO+CA group. The control group was added with PBS,ISO group treated with ISO(10μmol/L),and ISO+CA group added with ISO (10μmol/L)and different concentrations of CA(1,10,50,100μmol/L). After 48 h,the myocardial cells were collected and determined for ANP mRNA expression by real-time quantitative PCR,and the area of myocardial cell was measured by immunofluorescence staining. Results Compared with the control group, the cardiac volume,HM/BM and HM/TL ratios,and cross-sectional area of myocardial cells were increased in those of the ISO group(all P<0.05). Compared with the ISO group,CA treatment was shown to reduce the cardiac volume,the ratios of HM/BM and HM/TL,and the cross-sectional area of myocardial cells(all P<0.05). Real-time quantitative PCR showed that the expressions of ANP andβ-MHC mRNA were up-regulated in ISO-treated mice as compared with the control group,whereas CA treatment significantly inhibited the ISO-induced up-regulation of ANP andβ-MHC mRNA expressions(all P<0.05). Immunoblotting showed that the phosphorylation levels of protein kinase B(AKT),glycogen synthase kinase 3β(GSK3β)and extracellular signal-regulated kinase(ERK)were significantly upregulated in the cardiac tissues of ISO-treated mice,and the activation of these signal pathways was significantly inhibited by CA (all P<0.05). At 48 h after ISO treatment,the primary cultured rat cardiac myocytes showed significantly increased area and up-regulated level of ANP mRNA expression(both P<0.05). Compared with the ISO group,CA treatment at concentration of 10,50 and 100 μmol/L significantly reduced the ANP mRNA expressions in the cardiac myocytes;moreover, the myocyte area was significantly reduced with 100 μmol/L CA treatment (all P<0.05). Conclusion CA may inhibit ISO-induced cardiac hypertrophy.

Effect of astragalosides on intracellular calcium overload in cultured cardiac myocytes of neonatal rats.

Effects of astragalosides on the cultivation of calcium overload in rat cardiac myocytes

Protective Effect of Astragalosides on Myocardial Injury by Isoproterenol in SD Rats

Effects of Asiatic Acid on Isoproterenol Induced Myocardial Hypertrophy

Modification of Alterations in Cardiac Function and Sarcoplasmic Reticulum by Astragaloside Iv in Myocardial Injury in Vivo

Astragaloside Iv Improved Intracellular Calcium Handling in Hypoxia-Reoxygenated Cardiomyocytes Via the Sarcoplasmic Reticulum Ca2+-Atpase

Protective Action of Astragalosides on Myocardial Injury Induced by Isoproterenol in Rats

Cardioprotective Effects of Astragali Radix Against Isoproterenol‐induced Myocardial Injury in Rats and Its Possible Mechanism

Protective Effects of Astragaloside Ⅳ on Isoproterenol-Induced Cardiac Hypertrophy in Mice

Cardioprotection Activity and Mechanism of Astragalus Polysaccharide in Vivo and in Vitro

Protection of Astragaloside Derivate on Oxidative Stress and Hypertrophy in Cardiomyocytes

EFFECT OF ASTRAGALOSIDE ON VITAMIN D-RECEPTOR EXPRESSION AFTER ENDOTHELIN-1-INDUCED CARDIOMYOCYTE INJURY

Cardioprotective Effects of Astragalin against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart

Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways

Protective Effects of Astragaloside IV on High Glucose Induced Cardiac Myocytes Hypertrophy in Neonatal Rats

Effects of calycosin on isoprenaline-induced cardiac hypertrophy

Astragalosides Rescue Both Cardiac Function and Sarcoplasmic Reticulum Ca2+ Transport in Rats with Chronic Heart Failure

Preventive Effects of Astragaloside IV and Its Active Sapogenin Cycloastragenol on Cardiac Fibrosis of Mice by Inhibiting the NLRP3 Inflammasome.

Astragaloside Iv from Astragalus Membranaceus Shows Cardioprotection During Myocardial Ischemia in Vivo and in Vitro

Astragaloside Iv Attenuates Hypoxia-Induced Cardiomyocyte Damage in Rats by Upregulating Superoxide Dismutase-1 Levels

[Effect of Astragalus injection on cardiomyocyte apoptosis, endoplasmic reticulum stress and expression of connexin in cardiomyopathy rats induced by adriamycin]